1. Home
  2. JYNT vs NVRO Comparison

JYNT vs NVRO Comparison

Compare JYNT & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • NVRO
  • Stock Information
  • Founded
  • JYNT 2010
  • NVRO 2006
  • Country
  • JYNT United States
  • NVRO United States
  • Employees
  • JYNT N/A
  • NVRO N/A
  • Industry
  • JYNT Multi-Sector Companies
  • NVRO Medical/Dental Instruments
  • Sector
  • JYNT Miscellaneous
  • NVRO Health Care
  • Exchange
  • JYNT Nasdaq
  • NVRO Nasdaq
  • Market Cap
  • JYNT 154.2M
  • NVRO 134.5M
  • IPO Year
  • JYNT 2014
  • NVRO 2014
  • Fundamental
  • Price
  • JYNT $10.30
  • NVRO $3.79
  • Analyst Decision
  • JYNT Strong Buy
  • NVRO Hold
  • Analyst Count
  • JYNT 2
  • NVRO 14
  • Target Price
  • JYNT $17.50
  • NVRO $7.97
  • AVG Volume (30 Days)
  • JYNT 37.2K
  • NVRO 446.9K
  • Earning Date
  • JYNT 11-07-2024
  • NVRO 11-11-2024
  • Dividend Yield
  • JYNT N/A
  • NVRO N/A
  • EPS Growth
  • JYNT N/A
  • NVRO N/A
  • EPS
  • JYNT N/A
  • NVRO N/A
  • Revenue
  • JYNT $120,795,620.00
  • NVRO $419,146,000.00
  • Revenue This Year
  • JYNT $3.28
  • NVRO N/A
  • Revenue Next Year
  • JYNT N/A
  • NVRO $0.65
  • P/E Ratio
  • JYNT N/A
  • NVRO N/A
  • Revenue Growth
  • JYNT 5.26
  • NVRO N/A
  • 52 Week Low
  • JYNT $8.88
  • NVRO $3.52
  • 52 Week High
  • JYNT $17.82
  • NVRO $22.53
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 33.35
  • NVRO 37.79
  • Support Level
  • JYNT $11.31
  • NVRO $3.92
  • Resistance Level
  • JYNT $11.20
  • NVRO $4.29
  • Average True Range (ATR)
  • JYNT 0.37
  • NVRO 0.28
  • MACD
  • JYNT -0.14
  • NVRO -0.03
  • Stochastic Oscillator
  • JYNT 15.34
  • NVRO 26.67

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About NVRO Nevro Corp.

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.

Share on Social Networks: